Manfred Welslau Selected Research

Manfred Welslau Research Topics

Disease

28	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2012
6	Triple Negative Breast Neoplasms 05/2021 - 10/2019
5	Neoplasms (Cancer) 10/2022 - 03/2014
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2023 - 05/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2021
3	Infections 01/2018 - 04/2013
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 07/2017
2	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2015
2	Squamous Cell Carcinoma of Head and Neck 11/2021 - 07/2021
2	Thrombocytopenia (Thrombopenia) 01/2017 - 11/2012
2	Lymphoma (Lymphomas) 01/2016 - 04/2013
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016 - 04/2013
2	Diarrhea 03/2014 - 11/2012
1	Lymphatic Metastasis 02/2024
1	Anemia 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Leukopenia 01/2023
1	Residual Neoplasm 09/2022
1	Brain Neoplasms (Brain Tumor) 06/2022
1	Prostatic Neoplasms (Prostate Cancer) 04/2022
1	Pain (Aches) 04/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2021
1	Pathologic Complete Response 05/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Multiple Myeloma 08/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Sepsis (Septicemia) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Metabolic Brain Diseases (Encephalopathy, Metabolic) 01/2017

Drug/Important Bio-Agent (IBA)

8	Hormones (Hormone)IBA 03/2023 - 10/2019
6	Immunoconjugates (Immunoconjugate)IBA 03/2023 - 03/2014
6	Rituximab (Mabthera)FDA Link 02/2023 - 05/2005
5	Bendamustine Hydrochloride FDA Link 01/2021 - 05/2005
4	Immune Checkpoint InhibitorsIBA 06/2022 - 04/2020
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2022 - 12/2019
4	Capecitabine (Xeloda)FDA Link 06/2021 - 11/2012
4	Ado-Trastuzumab EmtansineIBA 10/2019 - 11/2012
3	sacituzumab govitecanIBA 03/2023 - 04/2021
3	pembrolizumabIBA 03/2023 - 09/2022
3	atezolizumabIBA 03/2023 - 12/2019
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 05/2021
3	PlatinumIBA 11/2021 - 07/2021
3	Trastuzumab (Herceptin)FDA Link 01/2017 - 11/2012
3	Lapatinib (GW572016)FDA Link 01/2017 - 11/2012
2	olaparibIBA 06/2023 - 03/2023
2	abemaciclibIBA 06/2023 - 03/2023
2	Biosimilar PharmaceuticalsIBA 02/2023 - 01/2023
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 11/2021
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 11/2021
2	Cetuximab (Erbitux)FDA Link 10/2022 - 07/2021
2	trastuzumab deruxtecanIBA 09/2022 - 06/2022
2	AlpelisibIBA 06/2022 - 04/2021
2	pertuzumabIBA 06/2021 - 10/2019
2	Prednisone (Sone)FDA LinkGeneric 08/2020 - 04/2013
2	taxaneIBA 01/2017 - 11/2012
1	Local AnestheticsIBA 03/2023
1	CT-P10IBA 02/2023
1	trifluridine tipiracil drug combinationIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 11/2022
1	encorafenibIBA 10/2022
1	tucatinibIBA 06/2022
1	Diphosphonates (Bisphosphonates)IBA 04/2022
1	Denosumab FDA Link 04/2022
1	talazoparibIBA 02/2022
1	giredestrantIBA 02/2022
1	Inosine Triphosphate (ITP)IBA 01/2022
1	romiplostim FDA Link 01/2022
1	NivolumabIBA 11/2021
1	neratinibIBA 06/2021
1	Cyclin-Dependent Kinase 4IBA 05/2021
1	polatuzumab vedotinIBA 01/2021
1	Bortezomib (Velcade)FDA Link 08/2020
1	Drug CombinationsIBA 08/2020
1	Monoclonal AntibodiesIBA 01/2018
1	pazopanib FDA Link 07/2017
1	Everolimus FDA Link 07/2017
1	MTOR InhibitorsIBA 07/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	fludarabineIBA 01/2016
1	purineIBA 01/2016
1	Leucovorin (Folinic Acid)FDA Link 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Sunitinib (Sutent)FDA Link 01/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2015
1	Bevacizumab (Avastin)FDA Link 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2014
1	ErbB Receptors (EGF Receptor)IBA 03/2014

Therapy/Procedure

27	Therapeutics 09/2023 - 03/2014
8	Drug Therapy (Chemotherapy) 06/2022 - 04/2013
3	Neoadjuvant Therapy 03/2023 - 05/2021
2	Radiotherapy 02/2024 - 07/2021
2	Immunotherapy 12/2019 - 10/2019
2	Precision Medicine 11/2018 - 11/2018
1	Combination Drug Therapy (Combination Chemotherapy) 12/2019